1. What, how, and when for the WHO: will the clock be turned back for the next hematolymphoid tumor classification?

   • William R. Macon

   Editorial 19 August 2021 Pages: 185 - 186

2. CD37 and CD44 evaluation by flow cytometry: can these markers improve B cell lymphoma characterization?

   • Joanna Chaffin
   • Sayedamin Mostofizadeh
   • Robert Seifert

   Original Article 21 May 2021 Pages: 187 - 196

   

3. Multiple myeloma and frequency of synchronous and second primary malignancies

   • Atakan Turgutkaya
   • İrfan Yavaşoğlu
   • Ali Zahit Bolaman

   Original Article 01 May 2021 Pages: 197 - 203

   

4. The impact of CD33/CD34 ratio in the prognosis of myelodysplastic syndrome treated with azacitidine for first-line therapy

   • Satoko Oka
   • Kazuo Ono

   Original Article 15 July 2021 Pages: 205 - 212

   

5. Polymerase chain reaction-restriction fragment length polymorphism method for detection of Calreticulin type-1 and type-2 mutations in myeloproliferative neoplasm

   • Shano Naseem
   • Jogeshwar Binota
   • Pankaj Malhotra

   Original Article 12 June 2021 Pages: 213 - 220

   

6. Blood cell morphology and COVID-19 clinical course, severity, and outcome

   • Amirhossein Pezeshki
   • Atefeh Vaezi
   • Pardis Nematollahi

   Original Article 05 July 2021 Pages: 221 - 228

   

7. Hemophagocytic lymphohistiocytosis, a new cause of death during ‘post-acute COVID-19 syndrome?’ A case report

   • Elie Naous
   • Bertha-Maria Nassani
   • Rita Medlej

   Case Report 20 April 2021 Pages: 229 - 233

   

8. Extracutaneous involvement of subcutaneous panniculitis-like T-cell lymphoma associated with hemophagocytic lymphohistiocytosis and refractory to intensive chemotherapy

   • S. H. T. Peng
   • B. Wong
   • L. A. Canterbury

   Case Report 05 May 2021 Pages: 235 - 242

   

9. Primary thyroid T cell lymphoproliferative disorder with a 10-year history of neck mass: a case report and literature review

   • Kyung Han Nam
   • Bomi Kim

   Case Report 12 May 2021 Pages: 243 - 250

   

10. Sequential development of JAK2^V617F and BCR-ABL1: a “double-hit” myeloproliferative neoplasm with morphologic transition

    • Yue Zhao
    • Jenna McCracken
    • Endi Wang

    Letter to the editor 24 May 2021 Pages: 251 - 253

    

11. Coexistence of pseudo-Pelger-Hüet anomaly and faggot cells in acute promyelocytic leukemia during chemotherapy

    • Ting Li
    • Dongyan Li
    • Xueyan Chen

    Letter to the editor 31 May 2021 Pages: 255 - 256

    

12. Medication-induced Pseudo-Pelger-Huët Anomaly and severe neutropenia

    • Krasimira A. Rozenova
    • Min Shi

    Images 21 May 2021 Pages: 257 - 259